|
The Pharmaceutical Company
Outlook to 2011: Financial and Strategic Analysis of the Sales
Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
Based on an analysis of 46 companies and 1,000+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 4.9% CAGR 200511. However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening.
View
Table Of Contents >
|
